Minimed Group, Inc.
MMED
$19.78
$0.281.44%
NASDAQ
| 04/24/2026 | 01/23/2026 | 10/24/2025 | 07/24/2025 | ||
|---|---|---|---|---|---|
| Revenue | 14.25% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 14.25% | -- | -- | -- | |
| Cost of Revenue | 19.29% | -- | -- | -- | |
| Gross Profit | 10.34% | -- | -- | -- | |
| SG&A Expenses | 9.54% | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | 342.86% | -- | -- | -- | |
| Total Operating Expenses | 15.55% | -- | -- | -- | |
| Operating Income | -90.91% | -- | -- | -- | |
| Income Before Tax | -30.34% | -- | -- | -- | |
| Income Tax Expenses | 146.15% | -- | -- | -- | |
| Earnings from Continuing Operations | -60.91% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | 0.00% | -- | -- | -- | |
| Net Income | -56.34% | -- | -- | -- | |
| EBIT | -90.91% | -- | -- | -- | |
| EBITDA | -9.66% | -- | -- | -- | |
| EPS Basic | -250.19% | -- | -- | -- | |
| Normalized Basic EPS | -179.36% | -- | -- | -- | |
| EPS Diluted | -250.49% | -- | -- | -- | |
| Normalized Diluted EPS | -179.36% | -- | -- | -- | |
| Average Basic Shares Outstanding | 3.03% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 103.02% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |